4//SEC Filing
Burgess Michael F. 4
Accession 0001104659-22-077447
CIK 0001773427other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:29 PM ET
Size
6.5 KB
Accession
0001104659-22-077447
Insider Transaction Report
Form 4
Burgess Michael F.
Head of Research & Development
Transactions
- Award
Common Stock
2022-06-30+12,185→ 52,687 total - Tax Payment
Common Stock
2022-06-01$19.61/sh−2,672$52,398→ 40,502 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person.
- [F2]Represents restricted stock awards, which became fully vested on June 30, 2022.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001801745
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 5:29 PM ET
- Size
- 6.5 KB